Between: Mon to Fri: 9 AM to 6 PM IST
Sat: 9 AM to 1 PM IST
| CAGR since inception | |
|---|---|
Sector allocation
| Name | % of Net Assets |
|---|---|
| BLUEBOX GLOBAL TECHNOLOGY FUND | 36.07% |
| ISHARES NASDAQ 100 UCITS ETF | 26.55% |
| KRANESHARES CSI CHINA INTRNT | 15.5% |
| IVZ NASDAQ 100 EW ACC | 12.74% |
| FIDELITY SELECT MEDICAL TECHNOLOGY AND DEVICES PORTFOLIO | 4.88% |
| See detailed equity holdings » | |
Credit rating profile
Instrument break-up
| Name | % of Net Assets |
|---|---|
| TREPS / REVERSE REPO INVESTMENTS | 2.37% |
| See detailed debt holdings » | |
Kaivalya joined DSP in September 2024. She has over 6 years of work experience across Fund Management, Equity Dealing and Fund Accounting. Prior to joining DSP she has worked with ICICI Prudential AMC. Kaivalya is a Chartered Accountant from the Institute of Chartered Accountants of India. She has also cleared the Company Secretary Professional Level from the Institute of Company Secretaries of India and CFA Level III Examination from the CFA Institute.
| Sr. No. | Scheme Name | Managing since | Period | |||||
|---|---|---|---|---|---|---|---|---|
| 1 Year | 3 Years | 5 Years | ||||||
|
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement Different plans shall have a different expense structure. The performance details provided herein are of regular plan. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments |
||||||||
| Name | % of Net Assets | BLUEBOX GLOBAL TECHNOLOGY FUND | 36.07% | ISHARES NASDAQ 100 UCITS ETF | 26.55% | KRANESHARES CSI CHINA INTRNT | 15.5% | IVZ NASDAQ 100 EW ACC | 12.74% | FIDELITY SELECT MEDICAL TECHNOLOGY AND DEVICES PORTFOLIO | 4.88% | BLUEBOX PRECISION MEDICINE FUND | 2.25% |
|---|
| Name | Rating | % of Net Assets |
|---|---|---|
| TREPS / REVERSE REPO INVESTMENTS | -- | 2.37% |
The primary investment objective of the scheme is to seek capital appreciation by investing in global mutual fund schemes and ETFs that primarily invest in companies with innovation theme having potential for higher revenue and earnings growth.
The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP Mutual Fund, in order to meet liquidity requirements from time to time.
However, there is no assurance that the investment objective of the Scheme will be realized.
The Scheme intends to invest in following Innovation Funds:
iShares PHLX Semiconductor ETF
BGF World Tech Fund D2 USD
iShares NASDAQ 100 UCITS ETF
Baillie Gifford Worldwide Long term Global growth Fund
Nikko AM ARK Disruptive Innovation Fund
Morgan Stanley US Insight Fund
Bluebox Global Technology Fund
Invesco NASDAQ-100 Equal Weight UCITS ETF
Bluebox Precision Medicine Fund
Fidelity Select Medical Technology and Devices Portfolio
HSBC Hang Seng TECH UCITS ETF
KraneShares CSI China Internet UCITS ETF